Business · 09/10/2020Updated: 10/17/2026 · 1 min read
Novartis Pharmaceuticals Corp., et al.; Withdrawal of FDA Approval for 13 New Drug Applications
Summary
The US Food and Drug Administration (FDA) is withdrawing approval for 13 new drug applications submitted by multiple pharmaceutical companies, following notifications that the approved drugs are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →